BDX Q3 2023 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena

BDXBecton, Dickinson and Company

$60B

Q3 2023 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$4.9B+5.1% YoY

Gross Profit

$2.1B43.1% margin

Operating Income

$549M11.3% margin

Net Income

$407M8.3% margin

EPS (Diluted)

$1.36

QoQ Revenue Growth

+1.2%

Cash Flow

Operating Cash Flow

$1.1B

Free Cash Flow

$889M

Stock-Based Comp.

$56M

Balance Sheet

Total Assets

$53.0B

Total Liabilities

$27.1B

Stockholders' Equity

$25.9B

Cash & Equivalents

$923M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.9B	$4.6B	+5.1%
Gross Profit	$2.1B	$2.1B	+1.6%
Operating Income	$549M	$537M	+2.2%
Net Income	$407M	$360M	+13.1%

Revenue Segments

Medical

$2.4B50%

Life Sciences

$1.2B25%

Interventional

$1.2B25%

Geographic Segments

UNITED STATES

$2.8B57%

Non-US

$2.1B43%